LENZ (LENZ Therapeutics) Additional Paid-In Capital : $347.12 Mil(As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Additional Paid-In Capital?

LENZ Therapeutics's quarterly additional paid-in capital increased from Mar. 2024 ($310.06 Mil) to Jun. 2024 ($315.13 Mil) and increased from Jun. 2024 ($315.13 Mil) to Sep. 2024 ($347.12 Mil).

LENZ Therapeutics's annual additional paid-in capital increased from Dec. 2021 ($0.25 Mil) to Dec. 2022 ($1.10 Mil) and increased from Dec. 2022 ($1.10 Mil) to Dec. 2023 ($2.52 Mil).

LENZ Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for LENZ Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Additional Paid-In Capital Chart

LENZ Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Additional Paid-In Capital

0.25

1.10

2.52

LENZ Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Additional Paid-In Capital	Get a 7-Day Free Trial					1.98	2.52	310.06	315.13	347.12

LENZ Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

LENZ Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014

Website

https://www.lenz-tx.com

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.